「疑いの病」とも呼ばれる強迫性障害（OCD）に対し、マジックマッシュルームに含まれる成分がもたらす可能性を検証した新刊が出版された。
本書の抜粋では、ニューヨークの街中でアダム・ストラウスがヘッドホンのコードを握りしめながら、2台のMP3プレーヤーの間で葛藤する場面が描かれている。本作はOCDを「不確実性」の問題と捉え、シロシビンがその疑念を軽減する助けとなり得るのかという問いを投げかけている。
強迫性障害の治療におけるシロシビン療法の可能性を探る新刊
AIによるレポート
関連記事
A placebo-controlled trial has shown that a single dose of psilocybin, the active ingredient in magic mushrooms, leads to rapid and lasting reductions in obsessive-compulsive disorder symptoms among treatment-resistant patients. The effects persisted for at least 12 weeks in participants who had not responded to conventional therapies. Researchers highlight the potential of this psychedelic for mental health treatment, though larger studies are needed.
AIによるレポート
President Donald Trump signed an executive order on Saturday directing federal agencies to accelerate access to psychedelic drugs like psilocybin and ibogaine for treating mental health conditions, including depression, anxiety, and PTSD. The order allocates $50 million in funding and instructs the FDA to prioritize reviews. Trump was joined by Health and Human Services Secretary Robert F. Kennedy Jr., Dr. Mehmet Oz, former Navy SEAL Marcus Luttrell, and podcast host Joe Rogan.
Science journalist Michaeleen Doucleff appeared on CBS Saturday Morning to discuss her new book, Dopamine Kids. She offered advice for parents aiming to reduce their children's screen time and junk food consumption. The discussion highlights practical strategies rooted in scientific insights.
AIによるレポート
A randomized clinical trial found that 24 minutes of specially designed music paired with auditory beat stimulation significantly lowers anxiety symptoms. Researchers at Toronto Metropolitan University tested various listening durations on 144 adults with moderate anxiety. The 24-minute session provided the strongest benefits.
2026/05/01 12:13